Daiichi Sankyo Co., Ltd. (DSNKY)
18.00
-0.02
(-0.11%)
USD |
OTCM |
Aug 24, 16:00
Daiichi Sankyo Enterprise Value : 31.92B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 31.92B |
| August 21, 2026 | 31.96B |
| August 20, 2026 | 31.99B |
| August 19, 2026 | 31.18B |
| August 18, 2026 | 29.88B |
| August 17, 2026 | 29.70B |
| August 14, 2026 | 30.43B |
| August 13, 2026 | 31.01B |
| August 12, 2026 | 31.54B |
| August 11, 2026 | 31.34B |
| August 10, 2026 | 31.39B |
| August 07, 2026 | 31.10B |
| August 06, 2026 | 29.88B |
| August 05, 2026 | 28.99B |
| August 04, 2026 | 28.28B |
| August 03, 2026 | 29.19B |
| July 31, 2026 | 28.54B |
| July 30, 2026 | 32.34B |
| July 29, 2026 | 31.34B |
| July 28, 2026 | 31.68B |
| July 27, 2026 | 30.87B |
| July 24, 2026 | 30.56B |
| July 23, 2026 | 30.12B |
| July 22, 2026 | 30.21B |
| July 21, 2026 | 31.05B |
| Date | Value |
|---|---|
| July 20, 2026 | 30.70B |
| July 17, 2026 | 30.79B |
| July 16, 2026 | 30.41B |
| July 15, 2026 | 29.35B |
| July 14, 2026 | 29.37B |
| July 13, 2026 | 29.65B |
| July 10, 2026 | 30.27B |
| July 09, 2026 | 30.21B |
| July 08, 2026 | 29.65B |
| July 07, 2026 | 29.77B |
| July 06, 2026 | 30.39B |
| July 02, 2026 | 29.10B |
| July 01, 2026 | 28.24B |
| June 30, 2026 | 28.59B |
| June 29, 2026 | 28.91B |
| June 26, 2026 | 28.21B |
| June 25, 2026 | 28.07B |
| June 24, 2026 | 27.92B |
| June 23, 2026 | 27.81B |
| June 22, 2026 | 28.05B |
| June 18, 2026 | 30.16B |
| June 17, 2026 | 28.92B |
| June 16, 2026 | 28.00B |
| June 15, 2026 | 28.43B |
| June 12, 2026 | 28.12B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astellas Pharma, Inc. | 29.10B |
| AstraZeneca PLC | 543.37B |
| Takeda Pharmaceutical Co., Ltd. | 85.21B |
| Ono Pharmaceutical Co., Ltd. | 6.571B |
| Shionogi & Co., Ltd. | 17.95B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 430.72M |
| Revenue (Quarterly) | 3.607B |
| Total Expenses (Quarterly) | 3.176B |
| EPS Diluted (Quarterly) | 0.2366 |
| Gross Profit Margin (Quarterly) | 78.37% |
| Profit Margin (Quarterly) | 11.94% |
| Earnings Yield | 4.74% |
| Operating Earnings Yield | 3.84% |
| Normalized Earnings Yield | 4.741 |